FR2034699B1 - - Google Patents

Info

Publication number
FR2034699B1
FR2034699B1 FR7007917A FR7007917A FR2034699B1 FR 2034699 B1 FR2034699 B1 FR 2034699B1 FR 7007917 A FR7007917 A FR 7007917A FR 7007917 A FR7007917 A FR 7007917A FR 2034699 B1 FR2034699 B1 FR 2034699B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7007917A
Other languages
French (fr)
Other versions
FR2034699A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of FR2034699A1 publication Critical patent/FR2034699A1/fr
Application granted granted Critical
Publication of FR2034699B1 publication Critical patent/FR2034699B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7007917A 1969-03-06 1970-03-05 Expired FR2034699B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1711869 1969-03-06

Publications (2)

Publication Number Publication Date
FR2034699A1 FR2034699A1 (enExample) 1970-12-11
FR2034699B1 true FR2034699B1 (enExample) 1974-08-30

Family

ID=11935108

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7007917A Expired FR2034699B1 (enExample) 1969-03-06 1970-03-05

Country Status (4)

Country Link
US (1) US3670080A (enExample)
CA (1) CA945473A (enExample)
FR (1) FR2034699B1 (enExample)
GB (2) GB1305742A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
US5919499A (en) * 1997-03-03 1999-07-06 Lawley, Inc. Aiding fermentation digestion and metabolism in mammals
MX2008015015A (es) * 2006-05-26 2008-12-05 Toyama Chemical Co Ltd Composicion oral que incluye acido propionico 3-{5-[4-(ciclopentiloxi)-2-hidroxibenzoil]-2-[(3-hidroxi-1,2-benz isoxazol-6-il)metoxi]fenil} o una sal del mismo.
WO2012142452A2 (en) 2011-04-13 2012-10-18 Biosafe Technologies, Inc. Cleaning, insecticide, insect repellant, glue solvent and anti-irritation composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1554967A (enExample) * 1967-01-28 1969-01-24

Also Published As

Publication number Publication date
GB1305741A (enExample) 1973-02-07
DE2010758B2 (de) 1976-11-18
DE2010758A1 (de) 1970-09-17
FR2034699A1 (enExample) 1970-12-11
US3670080A (en) 1972-06-13
GB1305742A (enExample) 1973-02-07
CA945473A (en) 1974-04-16

Similar Documents

Publication Publication Date Title
AU2270770A (enExample)
AU465452B2 (enExample)
AU429630B2 (enExample)
AU450150B2 (enExample)
FR2034699B1 (enExample)
AU442375B2 (enExample)
AU470301B1 (enExample)
AU427401B2 (enExample)
AU442535B2 (enExample)
AU410358B2 (enExample)
AU428131B2 (enExample)
AU428074B2 (enExample)
AU470661B1 (enExample)
AU428129B2 (enExample)
AU442285B2 (enExample)
AU442322B2 (enExample)
AU414607B2 (enExample)
AU425297B2 (enExample)
AU442380B2 (enExample)
AU442463B2 (enExample)
AU417208B2 (enExample)
AU442538B2 (enExample)
AU442554B2 (enExample)
AT308690B (enExample)
AR203167Q (enExample)